Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy
The therapeutic index of chemotherapeutic agents can be improved by the use of nano-carrier-mediated chemotherapeutic delivery. Ligand-targeted drug delivery can be used to achieve selective and specific delivery of chemotherapeutic agents to cancer cells. In this study, we prepared a peptidomimetic...
Main Authors: | Himgauri Naik, Jafrin Jobayer Sonju, Sitanshu Singh, Ioulia Chatzistamou, Leeza Shrestha, Ted Gauthier, Seetharama Jois |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/3/221 |
Similar Items
-
A comparison between liposomal and nonliposomal formulations of doxorubicin in the treatment of cancer: An updated review
by: Yik Hoe Ngan, et al.
Published: (2016-01-01) -
Morphological changes of doxorubicin-loaded liposomes observed by atomic force microscopy
by: Naoki Takahashi, et al.
Published: (2016-02-01) -
Doxorubicin Loaded Liposomal Nanoparticles Containing Quantum Dot for Treatment of Breast Cancer
by: Javad Shahabi, et al.
Published: (2019-10-01) -
Recurrent Meningioma of the Cervical Spine, Successfully Treated with Liposomal Doxorubicin
by: William L. Read, et al.
Published: (2017-07-01) -
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
by: Singh S
Published: (2018-03-01)